15 March 2017
Sofitel Legend Amsterdam The Grand
BioCapital Europe 2017, organised by LSP (Life Sciences Partners) is delighted to announce its 15th consecutive event, taking place on in March 2017 in Amsterdam, The Netherlands. For the 7th year running, the event will be held at the luxurious and historic hotel Sofitel Legend The Grand Amsterdam, the former town hall situated in the heart of Amsterdam.
BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe. Attendance is by invitation only. In 2016, the event attracted over 200 attendees (mainly CEOs, CFOs, pharma execs, VCs, and Institutional Investors). VCs and Institutional Investors are invited to attend free of charge to this event.
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.
For more information, please visit lspvc.com.